{"nct_id":"NCT01482962","title":"Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma","status":"COMPLETED","status_verified_date":"2018-07","start_date":"2012-06-11","start_date_type":"ACTUAL","primary_completion_date":"2015-06-30","primary_completion_date_type":"ACTUAL","completion_date":"2017-12-18","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}